[1] DE AZEVEDO CR,THULER LC,DE MELLO MJ,et al.Neoadjuvant chemotherapy rollowed by chemoradiation in cervical carcinoma:a review[J].Int J Gynecol Cancer,2016,26(4):729.
[2] SINGH U,AHIRWAR N,RANI AK,et al.The efficacy and safety of neoadjuvant chemotherapy in treatment of locally advanced carcinoma cervix[J].J Obstet Gynecol India,2013,64(4):273.
[3] ANGIOLI R,PLOTTI F,LUVERO D,et al.Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced carcinoma cancer:a pilot study[J].Tumor Biol,2014,35(3):2741.
[4] YAMAGUCHI S,NISHIMURA R,YAEGASHI N,et al.Phase Ⅱ study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ⅰb2 to Ⅱb,cervical squamous cell carcinoma:Japanese Gynecologic Oncology Group study (JGOG 1065)[J].Oncol Rep,2012,28(2):487.
[5] SHOJI T,TAKATORI E,SAITO T,et al.Neoadjuvant chemotherapy using platinum-and taxane-based regimens for bulky stage Ⅰb2 to Ⅱb non-squamous cell carcinoma of the uterine cervix[J].Cancer Chemother Pharmacol,2013,71(3):657.
[6] PRUEKSARITANOND N,CHAISARN P,YANARANOP M.The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage ⅠB-ⅡA cervical cancer[J].J Med Assoc Thai,2012,95(Suppl 3):S55.
[7] MIZUNUMA M,YOKOYAMA Y,FUTAGAMI M,et al.The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer[J].Int J Clin Oncol,2015,20(5):1.
[8] HOSAKA M,WATARI H,KATO T,et al.Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy[J].J Surg Oncol,2012,105(6):612.
[9] SONODA K,YAHATA H,ICHINOE A,et al.Retrospective Analysis of Concurrent Chemoradiation with Ariweekly Cisplatin plus 5-Fluorouracil Ersus Weekly Cisplatin in Cervical Cancer[J].Anticancer Res,2015,35(6):3447.